Apellis Pharmaceuticals (NASDAQ:APLS) Now Covered by Royal Bank of Canada

Sedang Trending 1 minggu yang lalu

Royal Bank of Canada began sum connected Apellis Pharmaceuticals successful a investigation study connected Friday. They group a "sector perform" standing and a $25.00 target value for nan company.

This communicative appeared connected marketbeat.com, 2024-10-25 11:48:45.

Sumber Syndicate
Syndicate